Central Institute of Mental Health, Department of Addictive Behaviour and Addiction Medicine, Mannheim, Germany.
Chair in Addiction Research, Medical Faculty Mannheim/Heidelberg University, University of Heidelberg, Heidelberg, Germany.
Eur Addict Res. 2022;28(4):309-322. doi: 10.1159/000522335. Epub 2022 Apr 19.
Alcohol consumption in Germany is associated with considerable health and economic consequences. In addition to prevention, the early detection and differential treatment of those affected play an important role. The guideline "Screening, Diagnosis, and Treatment of Alcohol Use Disorders" forms the basis of this care for people suffering from alcohol use disorders. Regular updates integrate the current state of research evidence and clinical expertise.
Under the auspices of the German Society for Psychiatry, Psychotherapy, Psychosomatics, and Neurology and the German Society for Addiction Research and Addiction Therapy e.V. (DG-Sucht), the 2019-2020 S3 guideline on alcohol was revised by eight working groups. Thirty-five professional societies participated in a structured consensus process to deliberate the recommendations. Potential conflicts of interest were examined in advance, documented, and taken into account during the voting on the recommendations.
The guideline provides recommendations on screening and brief interventions for different groups of people, as well as on treatment of individuals in the acute and post-acute phases of withdrawal. Special emphasis was placed on the treatment of comorbid somatic and psychological disorders. In addition, recommendations for specific groups of people (e.g., children and adolescents, pregnant women) have been made and adapted to the German care landscape.
德国的饮酒行为与相当多的健康和经济后果相关。除了预防之外，早期发现和对受影响者的差异化治疗也起着重要作用。《酒精使用障碍的筛查、诊断和治疗指南》为受酒精使用障碍影响的人群提供了护理的基础。定期更新纳入了当前的研究证据和临床专业知识。
在德国精神病学、心理治疗、身心医学和神经病学学会以及德国成瘾研究和成瘾治疗学会（DG-Sucht）的主持下，对 2019-2020 年 S3 酒精指南进行了修订，由八个工作组进行修订。三十五个专业协会参与了结构化共识过程，对建议进行了审议。在对建议进行投票之前，预先检查了潜在的利益冲突，并将其记录在案并在投票时加以考虑。
该指南就不同人群的筛查和简短干预措施以及个体在戒断的急性和后期阶段的治疗提供了建议。特别强调了共病躯体和心理障碍的治疗。此外，还为特定人群（例如儿童和青少年、孕妇）制定了建议，并根据德国的护理情况进行了调整。
